| Patient | Sir John Franklin |
|---|---|
| Date of birth | 1967-04-16 |
| Identifiers | MRN HR-EX005-SYN; SSN (made up) 000-05-3328 |
| Document date | 2026-03-10 |
| Author | Cordelia Ashby-Nwankwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit before a multi-year Arctic expedition. [S]
Sir John is a 58-year-old naval officer with stage 2 hypertension on amlodipine, class 1 obesity, mild noise-induced hearing loss and vitamin D insufficiency on vitamin D3, who is preparing to command an Arctic expedition expected to last two to three years, and comes for his preventive visit two weeks after his four-week review. He has recovered from influenza except for a dry cough on cold mornings, and he walks three to four miles a day again. His home readings this week average 131/81. He has lost 2.4 kg since intake by walking, hill climbing and smaller portions. His dentist examined him last week, took films and replaced a cracked filling. He had influenza and COVID-19 vaccines in the autumn and his last tetanus booster was more than ten years ago; he has never had pneumococcal, zoster, hepatitis B or rabies vaccines. He has never had colorectal cancer screening. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 58, nine weeks before sailing |
| Blood pressure | Home average 131/81 on amlodipine 5 mg |
| Weight | 88.4 kg, from 90.8 at intake |
| Mood | PHQ-2 0 |
| Medicines | Amlodipine 5 mg daily; vitamin D3 25 micrograms daily |
Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him by Dr. Ashby-Nwankwo. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good; better since the influenza passed |
| Psychosocial | Married; busy with the expedition's preparations; the end of his last post still weighs on him, and he sees the command as a chance to set that right |
| Alcohol | One glass of wine with dinner on most days, down from two; AUDIT-C 3 at intake |
| Tobacco | Never |
| Physical activity | Walks three to four miles a day, with hills twice a week |
| Nutrition | Smaller portions, more vegetables and fruit, less salt and fewer puddings |
| Sleep | Seven hours; no snoring reported, no daytime sleepiness |
| Safety | Wears a seat belt; no firearms at home; uses hearing protection on the gun deck |
| Activities of daily living | Independent |
| Hearing and vision | Trouble hearing in noisy rooms; reading glasses; eye examination last year |
| Oral health | Dental examination and a replaced filling last week |
| Travel | Two to three years in the Arctic with no outside contact; ship's surgeons on board; no evacuation possible for months at a time |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy back; weight down 2.4 kg by intention |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Positive | Trouble hearing in noisy rooms, unchanged |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Positive | Dry cough on cold mornings, fading; no breathlessness |
| Gastrointestinal | Negative | No bleeding, change in bowel habit or indigestion |
| Genitourinary | Negative | Gets up once at night to pass urine; no hesitancy |
| Musculoskeletal | Negative | Mild knee stiffness after hills; no joint swelling |
| Integumentary | Negative | No new skin lesions |
| Neurological | Negative | No numbness, weakness or headaches |
| Psychiatric | Negative | Mood good; PHQ-2 0 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet once daily | One tablet by mouth every morning | Oral route | 2026-01-27 | active | S |
| Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily, continued through the polar winters | One tablet by mouth daily | Oral route | 2026-01-27 | active | S |
| Oseltamivir 75 mg oral capsule twice daily for five days | One capsule by mouth twice a day for five days | Oral route | 2026-02-10 to 2026-02-14 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-10 | Body height | 170 | cm | S |
| 2026-03-10 | Body weight | 88.4 | kg | S |
| 2026-03-10 | Body mass index (BMI) [Ratio] | 30.6 | kg/m2 | S |
| 2026-03-10 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-03-10 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-03-10 | Heart rate | 72 | /min | S |
| 2026-03-10 | Respiratory rate | 14 | /min | S |
| 2026-03-10 | Body temperature | 36.6 | Cel | S |
| 2026-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-10 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 2026-03-10; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 88.4 kg, BMI 30.6; blood pressure 132/80; pulse 72 and regular |
| Ears, nose, mouth, and throat | Ear canals clear; teeth in good repair |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear to auscultation |
| Abdomen | Soft and non-tender; no aortic pulsation felt |
| Skin | No suspicious lesions |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| High blood pressure found at the pre-expedition medical (152/94 mmHg, average of two readings), without a prior diagnosis; home readings for one week ordered to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding at a pre-expedition fitness assessment, anchored to the documented doubts about his fitness; superseded when home readings confirmed hypertension. |
| Essential hypertension, stage 2 by home readings (one-week average 144/90 mmHg), without target-organ damage; synthetic | active | confirmed | I10 | S — Synthetic modern diagnosis confirmed by home monitoring at the consultation; no blood pressure from his lifetime is recorded. |
| Obesity, class 1 (BMI 31.4 at intake), with a waist of 106 cm; he sets his own goals for activity and food | active | confirmed | E66.811 | S — Synthetic modern finding anchored to the documented description of his build as portly; no weight from his lifetime is recorded. |
| Medical preparation for a multi-year Arctic expedition beyond the reach of hospital care: fitness, cold injury, nutrition and food safety, vaccinations, dental care, mental health in isolation, a medical kit and an evacuation plan | active | confirmed | Z71.84 | S — Synthetic travel-health problem anchored to the documented expedition. |
| Bilateral high-frequency sensorineural hearing loss from noise, mild; trouble hearing in noisy rooms | active | confirmed | H83.3X3 | S — Synthetic modern coding of the documented mild hearing loss from naval gunfire; the audiogram is synthetic. |
| Vitamin D insufficiency in midwinter (25-hydroxyvitamin D 22 ng/mL), with years of polar darkness ahead | active | confirmed | E55.9 | S — Synthetic laboratory finding at intake. |
| Influenza A, confirmed by rapid molecular test, with fever, cough and aches, without pneumonia; treated with oseltamivir; recovered with a lingering cough | resolved | confirmed | J10.1 | S — Synthetic modern illness anchored to the documented severe influenza of the winter before the expedition; the test, course and treatment are synthetic. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 132/80 mmHg; treated hypertension |
| Lipid screening and cardiovascular risk | Up to date | Lipid panel at intake; PREVENT 10-year cardiovascular risk about 6 percent; statin discussed and declined for now |
| Diabetes screening | Up to date | HbA1c 5.6% at intake; recheck on return |
| Obesity counseling | Completed today | His own plan of walking, hills and smaller portions reviewed; 2.4 kg lost |
| Colorectal cancer screening | Ordered | Never screened; fecal immunochemical test today, as colonoscopy cannot be fitted in before sailing; colonoscopy if positive |
| Lung cancer screening | Not indicated | Never smoked |
| Abdominal aortic aneurysm screening | Not indicated | For men 65 to 75 who have ever smoked |
| Prostate cancer screening | Declined | Shared decision-making at 55 to 69; he chose not to have a PSA test |
| HIV screening | Ordered | Once for adults to 65; drawn today |
| Hepatitis C screening | Ordered | Once for all adults; drawn today |
| Hepatitis B screening | Ordered | Triple panel once for all adults; drawn before the first vaccine dose |
| Latent tuberculosis screening | Up to date | Interferon-gamma release assay negative at intake, after a household contact long ago |
| Depression screening | Completed today | PHQ-2 0 |
| Unhealthy alcohol use | Up to date | AUDIT-C 3 at intake; cutting back |
| Dental examination | Up to date | Examined with films last week; a cracked filling replaced; no other work needed before sailing |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap today; last booster more than ten years ago |
| Pneumococcal vaccine | Completed today | PCV20 today, recommended from 50; no further dose needed |
| Zoster vaccine | Completed today | First recombinant dose today; second before departure |
| Hepatitis B vaccine | Completed today | First HepB-CpG dose today; second in four weeks |
| Rabies pre-exposure prophylaxis | Completed today | First dose today, second in seven days; for years in the Arctic beyond the reach of rabies immune globulin |
| Influenza and COVID-19 vaccines | Up to date | Given last autumn; next doses on his return |
| RSV vaccine | Not indicated | Recommended at 50 to 74 only with conditions that raise risk; none |
Immunizations given today: Tetanus, diphtheria and acellular pertussis (Tdap) booster; Pneumococcal conjugate vaccine (PCV20), single dose; Recombinant zoster vaccine, first of two doses; Hepatitis B vaccine (HepB-CpG), first of two doses; Rabies vaccine (human diploid cell), pre-exposure prophylaxis, first of two doses [S]
Guideline basis: Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices, United States, 2022 (2022); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Colorectal Cancer: Screening (2021); Prostate Cancer: Screening (2018); Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 (2023); Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices, United States, 2022 (2022); Adult Immunization Schedule by Age (2026)
Follow-up: Second rabies dose with the nurse in one week. Fecal test and screening results by phone. Eight-week review with the exercise treadmill test and the second hepatitis B dose. Next scheduled visit 2026-04-07: eight-week review: blood pressure at goal, weight, exercise treadmill test and expedition planning. [S]
Voluntary advance care planning discussion of about 25 minutes, with his consent. He named a health care agent and completed a health care proxy form; the agent is recorded in the chart and is not named here. Because he will be beyond the reach of hospital care for months at a time, he talked through what he would want if he became seriously ill in the ice: care by the ship's surgeons with the medicines on board, relief of pain and breathlessness, and no attempt at a journey that would endanger others to move him. He asked that a copy of his wishes travel with his medical record on board. The plan will be revisited on his return or after any serious illness. [S]